HealthWarehouse.com Reports Results for Second Quarter 2026
HealthWarehouse.com reported Q2 net sales of $6.1 million, a 61% decrease year-over-year, driven by the FDA's termination of a program allowing compounded GLP-1 medications. The company posted a net loss of $414,000 and negative Adjusted EBITDA of $84,000, reversing prior-year income of $228,000.
Key figures
- Revenue
- 6133000
- Net loss
- 414000
- Otc sales
- 934000
- Gross margin
- 54.6%
- Gross profit
- 3350000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.